HER4 can be expressed as alternatively spliced isoforms in ovarian cancer cells [33] and expression of a specific HER4 isoform, cytoplasmic (CYT)-1, has been associated with both increased cell growth and poor survival [35]. This evidence concerns the gene ERBB4 and ovarian cancer.